A new blended genome genetic test being studied in a major clinical trial may help identify men at highest risk of aggressive prostate cancer and personalise screening strategies.

In India, prostate cancer is often diagnosed late, making treatment harder and survival outcomes worse due to lack of ...

Drugmaker Novartis’ Super Bowl ad explained that prostate cancer screening starts with a simple blood test, aiming to dispel ...

The prostate cancer diagnostics market size was estimated at USD 9.72 billion in 2025 and is projected to attain around USD 18 billion by 2035, growing at a notable CAGR of 6.36 % from 2026 to 2035.

NFL tight ends and prostate cancer survivor Bruce Arians star in a Super Bowl commercial promoting a new, finger-free PSA blood test for prostate cancer screening. The ad, praised by Dr. Firas ...

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

Many symptoms associated with prostate cancer, like frequent urination or difficulty peeing, may be caused by less-serious concerns. Learn more.

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Black men have one of the highest rates of prostate cancer. In fact, 1 in 6 will develop the disease in their lifetimes. And we also have twice the risk of dying from prostate cancer compared to White ...